Related Experiment Video
Updated: Jul 29, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Are patients with Parkinson's disease suicidal?
M Myslobodsky1, F M Lalonde, L Hicks
1Department of Psychology, Howard University, Washington, DC, USA.
Journal of Geriatric Psychiatry and Neurology
|September 21, 2001
Summary
Individuals with Parkinson's disease (PD) have a significantly lower suicide rate than the general population. This finding suggests that factors beyond mood disorders and comorbidities influence suicide risk in PD patients.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder with complex health implications.
- Suicide risk is a critical concern in neurological conditions, yet data on PD-specific suicide rates remain limited.
Purpose of the Study:
- To investigate and compare suicide rates between individuals diagnosed with Parkinson's disease and the general population.
- To identify potential demographic and clinical factors associated with suicide in Parkinson's disease patients.
Main Methods:
- Utilized mortality statistics from the National Center of Health Statistics (1991-1996).
- Analyzed data for 144,364 individuals aged 40+ with a primary Parkinson's disease diagnosis.
- Compared suicide rates and associated factors (age, gender, race, education, marital status, affective disorders, malignancy) between PD patients and a referent population.
Main Results:
- The suicide rate among Parkinson's disease patients (0.08%) was approximately 10 times lower than in the general population (0.8%).
- Demographic factors did not explain the observed difference in suicide rates.
- Patients with PD who died by suicide had significantly lower rates of affective disorders compared to PD patients who died from other causes.
- The general population showed higher rates of malignancy and lower rates of depression.
Conclusions:
- Suicide risk in Parkinson's disease is lower than previously assumed and not solely explained by demographic factors.
- Affective disorders and somatic comorbidities offer limited insight into completed suicide among PD patients.
- Further research is needed to understand the nuanced factors influencing suicide in the Parkinson's disease population.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...